TapewireFind a company

person · Reporting owner

Richards Timothy T.

Disclosed activity across 1 company

Tapewire entity
32084
SEC CIK
0001601831

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ClearPoint Neuro, Inc.CLPT · Entity 2367DirectorOctober 01, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ClearPoint Neuro, Inc.

Report date October 01, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect87,863 Reported balance After 2026-10-01 transaction · row 1
1 source row

Row 1 · 2026-10-01 · Grant · Acquired 319 · Balance 87,863

F1: These shares were issued pursuant to the issuer's Seventh Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were issued pursuant to the issuer's Seventh Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 3, 2026 00:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 319 $12.21 $3,894.99
Disclosure

SEC source: 0001193125-26-412434 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,863

F1 · price: These shares were issued pursuant to the issuer's Seventh Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2026.

Read SEC document
July 01, 2026 Filed Jul 7, 2026 00:05 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 222 $17.84 $3,960.48
Disclosure

SEC source: 0001193125-26-296614 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,544

F1 · price: These shares were issued pursuant to the issuer's Seventh Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2026.

Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionStock Options (right to buy) · Derivative 500 $10.00 Strike: $10.00 $5,000.00
Disclosure

SEC source: 0001193125-26-261835 · ownership.xml · derivative · entry 3

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 500 shares

Expires 2026-06-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This option was previously reported as covering 20,000 shares at an exercise price of $0.25 per share, but was adjusted to reflect the stock split that occurred on July 27, 2016.

F1 · derivative.underlying_shares: This option was previously reported as covering 20,000 shares at an exercise price of $0.25 per share, but was adjusted to reflect the stock split that occurred on July 27, 2016.

Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Tax withholdingCommon Stock 376 $13.30 $5,000.80
Disclosure

SEC source: 0001193125-26-261835 · ownership.xml · nonDerivative · entry 2

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,322

Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionCommon Stock 500 $10.00 $5,000.00
Disclosure

SEC source: 0001193125-26-261835 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,698

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 20:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 SaleCommon Stock 5,415 $12.17 $65,900.55
Disclosure

SEC source: 0001193125-26-253602 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,198

F1 · kind: This sale of shares was made to cover the tax liability incident to the vesting of 12,417 shares on May 19, 2026 under a restricted stock unit granted to the director on May 22, 2025.

F2 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $12.04 to $12.47. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantRestricted Stock Units · Derivative 12,820 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-239441 · ownership.xml · derivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,820

Underlying: Common Stock · 12,820 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionRestricted Stock Units · Derivative 12,417 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-234570 · ownership.xml · derivative · entry 2

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,417 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:30 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionCommon Stock 12,417 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-234570 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,613

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 18:49 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 442 $9.10 $4,022.20
Disclosure

SEC source: 0001193125-26-139777 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,196

F1 · price: These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2026.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 23:46 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 884 $13.68 $12,093.12
Disclosure

SEC source: 0001193125-26-002935 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,754

F1 · price: These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2025.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:04 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 555 $21.79 $12,093.45
Disclosure

SEC source: 0001193125-25-228824 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,870

F1 · price: These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2025.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 21:03 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 934 $11.94 $11,151.96
Disclosure

SEC source: 0000950170-25-093154 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,315

F1 · price: These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2025.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 23:26 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 SaleCommon Stock 10,000 $13.28 $132,800.00
Disclosure

SEC source: 0000950170-25-085714 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,381

F1 · kind: This sale of shares was made to cover the tax liability incident to the vesting of 21,903 shares on May 16, 2025 under a restricted stock unit granted to the director on May 16, 2024.

F2 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $13.27 to $13.31. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 22, 2025 Filed May 23, 2025 21:45 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantRestricted Stock Units · Derivative 12,417 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077157 · ownership.xml · derivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,417

Underlying: Common Stock · 12,417 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders.

Read SEC document
May 16, 2025 Filed May 19, 2025 20:34 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionRestricted Stock Units · Derivative 21,093 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-074420 · ownership.xml · derivative · entry 2

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,093 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Read SEC document
May 16, 2025 Filed May 19, 2025 20:34 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionCommon Stock 21,093 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-074420 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 00:22 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 938 $11.89 $11,152.82
Disclosure

SEC source: 0000950170-25-049820 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,288

F1 · price: These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2025.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 21:51 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 725 $15.38 $11,150.50
Disclosure

SEC source: 0000950170-25-001304 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,350

F1 · price: These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2024.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 995 $11.21 $11,153.95
Disclosure

SEC source: 0001285550-24-000114 · wk-form4_1727900554.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,625

F1 · price: These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2024.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 21:19 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 2,069 $5.39 $11,151.91
Disclosure

SEC source: 0001285550-24-000084 · wk-form4_1719955190.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,630

F1 · price: These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 28, 2024.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:23 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantRestricted Stock Units · Derivative 21,093 $0.00 $0.00
Disclosure

SEC source: 0001285550-24-000067 · wk-form4_1715977372.xml · derivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,093

Underlying: Common Stock · 21,093 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders.

Read SEC document
May 14, 2024 Filed May 15, 2024 13:16 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionRestricted Stock Units · Derivative 17,153 $0.00 $0.00
Disclosure

SEC source: 0001285550-24-000053 · wk-form4_1715779003.xml · derivative · entry 2

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.

F2 · derivative.expiration_date: On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.

Read SEC document
May 14, 2024 Filed May 15, 2024 13:16 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 Exercise / conversionCommon Stock 17,153 Not disclosed Not disclosed
Disclosure

SEC source: 0001285550-24-000053 · wk-form4_1715779003.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:41 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,640 $6.80 $11,152.00
Disclosure

SEC source: 0001285550-24-000040 · wk-form4_1712090489.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,408

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 28, 2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 16:57 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,643 $6.79 $11,155.97
Disclosure

SEC source: 0001285550-24-000006 · wk-form4_1704301034.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,768

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 29, 2023.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 16:41 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 2,226 $5.01 $11,152.26
Disclosure

SEC source: 0001285550-23-000106 · wf-form4_169635129528956.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,125

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2023.

Read SEC document
July 03, 2023 Filed Jul 5, 2023 21:46 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,540 $7.24 $11,149.60
Disclosure

SEC source: 0001285550-23-000079 · wf-form4_168859356652618.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,899

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2023.

Read SEC document
May 25, 2023 Filed May 26, 2023 18:11 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantRestricted Stock Units · Derivative 17,153 $0.00 $0.00
Disclosure

SEC source: 0001285550-23-000063 · wf-form4_168512468308665.xml · derivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,153

Underlying: Common Stock · 17,153 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:57 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,321 $8.44 $11,149.24
Disclosure

SEC source: 0001285550-23-000039 · wf-form4_168064184614156.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,359

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2023.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:59 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,399 $7.97 $11,150.03
Disclosure

SEC source: 0001285550-23-000008 · wf-form4_167287314329964.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,038

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $7.97 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending December 30, 2022.

Read SEC document
October 03, 2022 Filed Oct 4, 2022 22:18 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,094 $10.19 $11,147.86
Disclosure

SEC source: 0001285550-22-000064 · wf-form4_166492186503764.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,639

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $10.19 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending September 30, 2022.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 18:37 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 883 $12.63 $11,152.29
Disclosure

SEC source: 0001285550-22-000030 · wf-form4_165713266139806.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,545

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $12.63 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending June 30, 2022.

Read SEC document
May 25, 2022 Filed May 27, 2022 20:27 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantStock Options (right to buy) · Derivative 6,179 $0.00 Strike: $9.71 $0.00
Disclosure

SEC source: 0001420506-22-001136 · doc4_1014.xml · derivative · entry 2

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

Read SEC document
May 25, 2022 Filed May 27, 2022 20:27 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 9,269 $0.00 $0.00
Disclosure

SEC source: 0001420506-22-001136 · doc4_1014.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,662

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:10 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,120 $9.96 $11,155.20
Disclosure

SEC source: 0001171520-22-000239 · eps10158.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,393

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $9.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2022.

Read SEC document
January 01, 2022 Filed Jan 4, 2022 12:17 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 644 $11.54 $7,431.76
Disclosure

SEC source: 0001171520-22-000014 · doc4_989.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,273

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $11.54 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2021.

Read SEC document
October 01, 2021 Filed Oct 4, 2021 20:13 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 414 $17.92 $7,418.88
Disclosure

SEC source: 0001420506-21-001359 · doc4_969.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,629

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $17.92 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended October 1, 2021.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:17 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 291 $20.26 $5,895.66
Disclosure

SEC source: 0001420506-21-000844 · doc4_936.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,215

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $20.26 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2021.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 12:36 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantStock Options (right to buy) · Derivative 6,006 $0.00 Strike: $19.98 $0.00
Disclosure

SEC source: 0001171520-21-000264 · ownership.xml · derivative · entry 2

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,006

Underlying: Common Stock · 6,006 shares

Expires 2031-06-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 12:36 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 3,003 $0.00 $0.00
Disclosure

SEC source: 0001171520-21-000264 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,924

F1 · shares: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 20:06 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 306 $19.57 $5,988.42
Disclosure

SEC source: 0001420506-21-000379 · doc4_921.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,921

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $19.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2021.

Read SEC document
December 31, 2020 Filed Jan 4, 2021 23:36 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 399 $15.00 $5,985.00
Disclosure

SEC source: 0001420506-21-000009 · doc4_893.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,615

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $15.00 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2020.

Read SEC document
September 30, 2020 Filed Oct 1, 2020 22:09 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,051 $5.71 $6,001.21
Disclosure

SEC source: 0001420506-20-001034 · doc4_860.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,216

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.71 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2020.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 17:31 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,687 $3.55 $5,988.85
Disclosure

SEC source: 0001171520-20-000287 · doc4_815.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,165

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.55 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2020.

Read SEC document
June 03, 2020 Filed Jun 17, 2020 20:12 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantStock Options (right to buy) · Derivative 15,000 $0.00 Strike: $4.13 $0.00
Disclosure

SEC source: 0001420506-20-000693 · doc4_809.xml · derivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2030-06-03

F1 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2021 annual meeting of stockholders.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 20:08 UTC ClearPoint Neuro, Inc. CLPT · Entity 2367 GrantCommon Stock 1,680 $3.57 $5,997.60
Disclosure

SEC source: 0001420506-20-000353 · doc4_796.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,478

F1 · price: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2020.

Read SEC document
December 31, 2019 Filed Jan 2, 2020 22:04 UTC ClearPoint Neuro, Inc. MRIC · Entity 2367 GrantCommon Stock 605 $4.96 $3,000.80
Disclosure

SEC source: 0001420506-20-000008 · doc4_781.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,798

F1 · price: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $4.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2019.

Read SEC document
September 30, 2019 Filed Oct 1, 2019 20:11 UTC ClearPoint Neuro, Inc. MRIC · Entity 2367 GrantCommon Stock 582 $5.15 $2,997.30
Disclosure

SEC source: 0001534424-19-000273 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,193

F1 · price: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2019.

Read SEC document
June 28, 2019 Filed Jul 1, 2019 20:11 UTC ClearPoint Neuro, Inc. MRIC · Entity 2367 GrantCommon Stock 947 $3.17 $3,001.99
Disclosure

SEC source: 0001534424-19-000199 · ownership.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,611

F1 · price: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.17 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 28, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.